Dr Erin McAllum is a NHMRC-ARC Dementia Research Development Fellow and early-career researcher at the Florey Institute of Neuroscience and Mental Health. She received her PhD from the University of Melbourne in 2016 and has a background in biochemistry and neuroscience with particular expertise in using bioanalytical techniques to investigate the role of metals in biology and neurodegenerative disease.
During her PhD, Dr McAllum contributed to the pre-clinical development of a novel therapeutic for the treatment of amyotrophic lateral sclerosis and Parkinson’s disease, now in clinical trials in Australia. Her current research focuses on the role of biological metals in dementia with Lewy bodies and Parkinson’s disease. She has a particular interest in how incorrect protein binding of these metals can lead to protein dysfunction. This includes investigating the role of metals in the pathological aggregation of certain proteins including alpha-synuclein and SOD1.
Her research uses a range of approaches to investigate this including mass spectrometry-based techniques, and X-ray fluorescence at the Australian Synchrotron. Dr McAllum was the recipient of a 2017 Victoria Fellowship enabling her to travel to Bordeaux, France to learn new approaches in applying particle-induced X-ray emission for the elemental analysis of biological tissue.
Dr McAllum is the Neuroscience Research Representative on the Australasian Neuroscience Society Council and Chair of the ANS EMCR sub-committee.
Awards and achievements
2017 Recipient of a Victoria Fellowship
2016 Recipient of a NHMRC-ARC Dementia Research Development Fellowship
Brain health affects all Australians. You can support our research by making a donation or a bequest.